REMEDY : BNSSG referral pathways & Joint Formulary

Home > Formulary : Paediatric > Paediatric Chapters > 2. Cardiovascular system >

BNSSG Paediatric Joint Formulary

2.9 Patent ductus arteriosus

Last edited: 15-01-2024

2.9 Patent ductus arteriosus

First line drugs Second line drugs Specialist drugs Secondary care drugs

Secondary Care to maintain responsibility for monitoring amber specialist initiated drugs in the cardiovascular section of the Paediatric formulary. A clear management plan detailed in the clinic letter is required to support primary care prescribing. GP Practices should ensure a plan is in place before taking over prescribing responsibility 

As per local guideline

Ibuprofen (TLS Red)

  • Closure of duct

Dinoprostone (TLS Red)


Alprostadil (TLS Red)

  • Opening duct